Vanguard Asset Management’s Damora Therapeutics DMRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$415K Sell
19,515
-5,793
-23% -$164K ﹤0.01% 2251
2026
Q2
$658K Buy
+25,308
New +$613K ﹤0.01% 2079

Other funds holding DMRA

Vanguard Asset Management's DMRA Position: Q3 2026 in Review

Vanguard Asset Management reduced its Damora Therapeutics (DMRA) stake by 23% in Q3 2026, selling an estimated $164K and leaving 19,515 shares worth $415K. The position accounts for ﹤0.01% of the portfolio, ranked #2251.

Vanguard Asset Management first reported a position in DMRA in Q2 2026 and has held it in 2 quarters since. The position peaked at $658K in Q2 2026. 115 funds tracked by Wall St. Rank hold DMRA as of Q3 2026.

  • Vanguard Asset Management held 19,515 shares of Damora Therapeutics worth $415K as of Q3 2026.
  • Vanguard Asset Management sold 5,793 Damora Therapeutics shares in Q3 2026, an estimated $164K.
  • Damora Therapeutics made up ﹤0.01% of Vanguard Asset Management's portfolio in Q3 2026, its #2251 holding.
  • Vanguard Asset Management first reported a position in Damora Therapeutics in Q2 2026 and has held it in 2 quarters since.
  • Vanguard Asset Management's Damora Therapeutics position peaked at $658K in Q2 2026.
  • 115 funds tracked by Wall St. Rank held Damora Therapeutics as of Q3 2026.

Based on Vanguard Asset Management's 13F filing for Q3 2026, filed 13 Nov 2026.